Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Renal Failure

  Free Subscription


Articles published in Nephrol Dial Transplant

Retrieve available abstracts of 173 articles:
HTML format



Single Articles


    November 2022
  1. HALIMI JM, de Freminville JB, Gatault P, Bisson A, et al
    Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
    Nephrol Dial Transplant. 2022;37:2386-2397.
    PubMed     Abstract available


  2. BOECKHAUS J, Hoefele J, Riedhammer KM, Nagel M, et al
    Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study.
    Nephrol Dial Transplant. 2022;37:2496-2504.
    PubMed     Abstract available


  3. YU B, Shi S, Lv J, Liu L, et al
    Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 Guideline.
    Nephrol Dial Transplant. 2022;37:2429-2437.
    PubMed     Abstract available


  4. DI H, Zhang J, Gao E, Zheng C, et al
    Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome.
    Nephrol Dial Transplant. 2022;37:2487-2495.
    PubMed     Abstract available


  5. PELLA E, Boutou A, Boulmpou A, Papadopoulos CE, et al
    Cardiopulmonary exercise testing in patients with end-stage kidney disease: principles, methodology and clinical applications of the optimal tool for exercise tolerance evaluation.
    Nephrol Dial Transplant. 2022;37:2335-2350.
    PubMed     Abstract available


  6. MATHUR VS, Bushinsky DA, Inker L, Klaerner G, et al
    Design and Population of the VALOR-CKD Study: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating the Efficacy and Safety of Veverimer in Slowing Progression of Chronic Kidney Disease in Patients with Metabolic Acidosis.
    Nephrol Dial Transplant. 2022 Nov 4. pii: 6776172. doi: 10.1093.
    PubMed     Abstract available


  7. PORRINI E, Perez NM, Diaz JM, Lauzurrica R, et al
    Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.
    Nephrol Dial Transplant. 2022 Nov 2. pii: 6794278. doi: 10.1093.
    PubMed     Abstract available


  8. GREINERT R, Greinert D, Eger AL, Ripoll C, et al
    Subclinical cognitive impairment in chronic kidney disease is associated with frailty and reduced quality of life.
    Nephrol Dial Transplant. 2022 Nov 2. pii: 6794277. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  9. HUNDEMER GL, Ravani P, Sood MM, Zimmerman D, et al
    Social determinants of health and the transition from advanced chronic kidney disease to kidney failure.
    Nephrol Dial Transplant. 2022 Oct 31. pii: 6783171. doi: 10.1093.
    PubMed     Abstract available


  10. HOSHINO J, Abe M, Hamano T, Hasegawa T, et al
    Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association.
    Nephrol Dial Transplant. 2022 Oct 29. pii: 6780212. doi: 10.1093.
    PubMed     Abstract available


  11. NEE R, Yuan CM, Narva AS, Yan G, et al
    Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease.
    Nephrol Dial Transplant. 2022 Oct 20. pii: 6764731. doi: 10.1093.
    PubMed     Abstract available


  12. CARRIAZO S, Aparicio-Madre MI, Tornero-Molina F, Fernandez-Lucas M, et al
    Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020.
    Nephrol Dial Transplant. 2022;37:2253-2263.
    PubMed     Abstract available


  13. MATHUR A, Ahn JB, Sutton W, Chu NM, et al
    Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia.
    Nephrol Dial Transplant. 2022;37:2111-2118.
    PubMed     Abstract available


  14. WANG Z, Jiang Y, Chen P, Wang J, et al
    The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study.
    Nephrol Dial Transplant. 2022;37:2119-2127.
    PubMed     Abstract available


  15. LINDEBOOM L, Lee S, Wieringa F, Groenendaal W, et al
    On the potential of wearable bioimpedance for longitudinal fluid monitoring in end-stage kidney disease.
    Nephrol Dial Transplant. 2022;37:2048-2054.
    PubMed     Abstract available


  16. MIYAMOTO Y, Katagiri R, Yamaji T, Inoue M, et al
    Association of chronic kidney disease with total and site-specific cancer incidence in participants of the Japan Public Health Center-based Prospective Study.
    Nephrol Dial Transplant. 2022 Oct 16. pii: 6761705. doi: 10.1093.
    PubMed     Abstract available


  17. DUONG MD, Wang S, Schwartz D, Mowrey WB, et al
    Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis.
    Nephrol Dial Transplant. 2022 Oct 11. pii: 6758516. doi: 10.1093.
    PubMed     Abstract available


  18. ORTIZ A, Wanner C, Gansevoort R
    Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association.
    Nephrol Dial Transplant. 2022 Oct 11. pii: 6752463. doi: 10.1093.
    PubMed    


  19. BASILE C, Casino FG, Mitra S
    Towards a tailored prescription of dialysis adequacy: the key role of incremental hemodialysis.
    Nephrol Dial Transplant. 2022 Oct 7. pii: 6753234. doi: 10.1093.
    PubMed    


    September 2022
  20. NILSSON E, Stenvinkel P, Liu S, Stedman MR, et al
    Testosterone concentrations andoutcomes in hemodialysis patients of the EVOLVE trial.
    Nephrol Dial Transplant. 2022 Sep 29. pii: 6731668. doi: 10.1093.
    PubMed     Abstract available


  21. BENECH N, Koppe L
    Is there a place for fecal microbiota transplantation in chronic kidney disease?
    Nephrol Dial Transplant. 2022 Sep 26. pii: 6717772. doi: 10.1093.
    PubMed    


  22. CAI X, Thorand B, Hohenester S, Koenig W, et al
    Association between the fatty liver index and chronic kidney disease: the population-based KORA study.
    Nephrol Dial Transplant. 2022 Sep 23. pii: 6712706. doi: 10.1093.
    PubMed     Abstract available


  23. KRON S, Schneditz D, Kron J
    The blood to extracellular volume relationship is stable and in the physiologic range in chronic haemodialysis patients.
    Nephrol Dial Transplant. 2022;37:2034-2036.
    PubMed    


  24. LOMONTE C, Basile C
    What the seminal experience of the Seattle Northwest Kidney Centers teaches to today's young nephrologists.
    Nephrol Dial Transplant. 2022;37:1789-1791.
    PubMed    


  25. DE JONG RW, Boezeman EJ, Chesnaye NC, Bemelman FJ, et al
    Work status and work ability of patients receiving kidney replacement therapy: results from a European survey.
    Nephrol Dial Transplant. 2022;37:2022-2033.
    PubMed     Abstract available


  26. MARTIN KJ
    How to evaluate phosphate control in patients on dialysis.
    Nephrol Dial Transplant. 2022;37:1830-1832.
    PubMed    


  27. FORTE V, Novelli S, Zaidan M, Snanoudj R, et al
    Microbiology and outcomes of polymicrobial peritonitis associated with peritoneal dialysis: a register-based cohort study from the French Language Peritoneal Dialysis Registry (RDPLF).
    Nephrol Dial Transplant. 2022 Sep 21. pii: 6710379. doi: 10.1093.
    PubMed     Abstract available


  28. CHEN HJ, Qiu J, Qi Y, Fu L, et al
    Hippocampal subfield morphology in regular hemodialysis patients.
    Nephrol Dial Transplant. 2022 Sep 17. pii: 6702744. doi: 10.1093.
    PubMed     Abstract available


  29. THIEM U, Hewitson TD, Toussaint ND, Holt SG, et al
    Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.
    Nephrol Dial Transplant. 2022 Sep 15. pii: 6701380. doi: 10.1093.
    PubMed     Abstract available


  30. KIM Y, Kang J, Chang Y, Hyun YY, et al
    Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults.
    Nephrol Dial Transplant. 2022 Sep 15. pii: 6701379. doi: 10.1093.
    PubMed     Abstract available


  31. YAMAGUCHI T, Yabe H, Kono K, Moriyama Y, et al
    Factors associated with dropout from an intradialytic exercise program among patients undergoing maintenance hemodialysis.
    Nephrol Dial Transplant. 2022 Sep 14. pii: 6697766. doi: 10.1093.
    PubMed     Abstract available


  32. HIRANO K, Kobayashi D, Shimbo T, Komatsu Y, et al
    Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease: an interrupted time-series study.
    Nephrol Dial Transplant. 2022 Sep 13. pii: 6696972. doi: 10.1093.
    PubMed     Abstract available


  33. BEURTON A, Fajardie A, Rubin S, Belnou P, et al
    Impact of previous REnal TRansplantation on the mid-term renal Outcome after CARdiac surgery: the RETROCAR trial.
    Nephrol Dial Transplant. 2022 Sep 13. pii: 6696971. doi: 10.1093.
    PubMed     Abstract available


  34. XIE D, Zhu Q, Lu J, Hu C, et al
    Development and validation of a diagnostic nomogram for sarcopenia in Chinese hemodialysis patients.
    Nephrol Dial Transplant. 2022 Sep 9. pii: 6695008. doi: 10.1093.
    PubMed     Abstract available


  35. MUREA M, Kalantar-Zadeh K
    Starting chronic hemodialysis twice-weekly: when less is more.
    Nephrol Dial Transplant. 2022 Sep 9. pii: 6695007. doi: 10.1093.
    PubMed    


  36. FARINA-HERNANDEZ A, Marrero-Miranda D, Perez-Carreno E, De Vera-Gonzalez A, et al
    Pretransplant evaluation and the risk of glucose metabolic alterations after renal transplantation: a prospective study.
    Nephrol Dial Transplant. 2022 Sep 9. pii: 6695005. doi: 10.1093.
    PubMed     Abstract available


  37. GEORGIANOS PI, Tziatzios G, Roumeliotis S, Vaios V, et al
    Effect of angiotensin converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 Sep 7. pii: 6693715. doi: 10.1093.
    PubMed     Abstract available


  38. SORENSEN IMH, Bjergfelt SS, Hjortkjaer HO, Kofoed KF, et al
    Coronary and extra-coronary artery calcium scores as predictors of cardiovascular events and mortality in chronic kidney disease stages 1-5: a prospective cohort study.
    Nephrol Dial Transplant. 2022 Sep 6. pii: 6692954. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  39. LOPES MB, Karaboyas A, Zhao J, Johnson DW, et al
    Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS.
    Nephrol Dial Transplant. 2022 Aug 27. pii: 6677977. doi: 10.1093.
    PubMed     Abstract available



  40. Correction to: Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Nephrol Dial Transplant. 2022 Aug 25. pii: 6675830. doi: 10.1093.
    PubMed    


  41. BOUWMANS P, Brandts L, Hilbrands LB, Duivenvoorden R, et al
    The clinical frailty scale as a triage tool for ICU admission of dialysis patients with COVID-19 - An ERACODA analysis.
    Nephrol Dial Transplant. 2022 Aug 24. pii: 6674776. doi: 10.1093.
    PubMed     Abstract available


  42. COLOMBO MG, Forster C, Wallwiener S, Hassdenteufel K, et al
    Comorbidity, life-style factors and health care utilization in incident chronic kidney disease: Sex-specific analyses of claims data.
    Nephrol Dial Transplant. 2022 Aug 23. pii: 6674223. doi: 10.1093.
    PubMed     Abstract available


  43. KETTELER M, Bover J, Mazzaferro S
    Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s.
    Nephrol Dial Transplant. 2022 Aug 17. pii: 6670816. doi: 10.1093.
    PubMed     Abstract available


  44. VAN DER WILLIK EM, van Breda F, van Jaarsveld BC, van de Putte M, et al
    Validity and reliability of Patient-Reported Outcomes Measurement Information System (PROMIS(R)) using Computerized Adaptive Testing (CAT) in patients with advanced chronic kidney disease.
    Nephrol Dial Transplant. 2022 Aug 1. pii: 6652904. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  45. COLLISTER D, Herrington G, Delgado L, Whitlock R, et al
    Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study.
    Nephrol Dial Transplant. 2022 Jul 26. pii: 6650227. doi: 10.1093.
    PubMed     Abstract available


  46. DAUGIRDAS JT
    Comparison of measured vs. kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration.
    Nephrol Dial Transplant. 2022 Jul 23. pii: 6649217. doi: 10.1093.
    PubMed     Abstract available


  47. OKUTE Y, Shoji T, Shimomura N, Tsujimoto Y, et al
    Serum phosphate as an independent factor associated with cholesterol metabolism in patients undergoing hemodialysis: a cross-sectional analysis of the DREAM cohort.
    Nephrol Dial Transplant. 2022 Jul 23. pii: 6649216. doi: 10.1093.
    PubMed     Abstract available



  48. Correction to: MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection.
    Nephrol Dial Transplant. 2022 Jul 15. pii: 6644904. doi: 10.1093.
    PubMed    


  49. ASSIMON MM, Pun PH, Al-Khatib SM, Brookhart MA, et al
    The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Nephrol Dial Transplant. 2022 Jul 6. pii: 6632991. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  50. ASHBY DR, Caplin B, Corbett RW, Asgari E, et al
    Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study.
    Nephrol Dial Transplant. 2022 Jun 29. pii: 6620856. doi: 10.1093.
    PubMed     Abstract available


  51. NADER R, Zhen A, Angel-Korman A, Pavlovich SS, et al
    Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis.
    Nephrol Dial Transplant. 2022;37:1281-1288.
    PubMed     Abstract available


  52. CARAVACA-FONTAN F, Diaz-Encarnacion M, Cabello V, Ariceta G, et al
    Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.
    Nephrol Dial Transplant. 2022;37:1270-1280.
    PubMed     Abstract available


  53. JAQUES DA, Ponte B, Haidar F, Dufey A, et al
    Outcomes of incident patients treated with incremental haemodialysis as compared to standard haemodialysis and peritoneal dialysis.
    Nephrol Dial Transplant. 2022 Jun 22. pii: 6613182. doi: 10.1093.
    PubMed     Abstract available


  54. DEAK AT, Belic K, Meissl AM, Artinger K, et al
    Salivary potassium measured by genetically encoded potassium ion indicators as a surrogate for plasma potassium levels in hemodialysis patients - a proof-of-concept study.
    Nephrol Dial Transplant. 2022 Jun 14. pii: 6608365. doi: 10.1093.
    PubMed     Abstract available


  55. GREEN JB, Mottl AK, Bakris G, Heerspink HJL, et al
    Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using an UACR Endpoint study (CONFIDENCE).
    Nephrol Dial Transplant. 2022 Jun 14. pii: 6608366. doi: 10.1093.
    PubMed     Abstract available


  56. WORBOYS HM, Cooper NJ, Burton JO, Young HML, et al
    Measuring Quality of Life in Trials Including Patients on Hemodialysis: Methodological Issues Surrounding use of the Kidney Disease Quality of Life Questionnaire. A Systematic Review.
    Nephrol Dial Transplant. 2022 Jun 11. pii: 6605927. doi: 10.1093.
    PubMed     Abstract available


  57. JUNG CY, Yun HR, Park JT, Joo YS, et al
    Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKD.
    Nephrol Dial Transplant. 2022 Jun 11. pii: 6605928. doi: 10.1093.
    PubMed     Abstract available


  58. NG JH, Izard S, Murakami N, Jhaveri KD, et al
    Outcomes of kidney transplantation in patients with myeloma and amyloidosis in the US.
    Nephrol Dial Transplant. 2022 Jun 10. pii: 6605285. doi: 10.1093.
    PubMed     Abstract available


  59. BROWN EA, Ekstrand A, Gallieni M, Gorrin MR, et al
    Availability of assisted peritoneal dialysis in Europe: call for increased and equal access.
    Nephrol Dial Transplant. 2022 Jun 7. pii: 6603817. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  60. HOLDEN RM, Booth SL, Zimmerman D, Moist L, et al
    Inhibit progression of coronary artery calcification with vitamin k in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-centre, pilot trial.
    Nephrol Dial Transplant. 2022 May 31. pii: 6596294. doi: 10.1093.
    PubMed     Abstract available


  61. MANFREDINI F, D'arrigo G, Lamberti N, Torino C, et al
    The legacy effect of a home walking exercise program in kidney failure patients on dialysis.
    Nephrol Dial Transplant. 2022 May 31. pii: 6596293. doi: 10.1093.
    PubMed     Abstract available


  62. EINBINDER Y, Hornik-Lurie T, Cohen-Hagai K, Goldman S, et al
    Correction to: Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
    Nephrol Dial Transplant. 2022 May 26. pii: 6593853. doi: 10.1093.
    PubMed    


  63. DE BORST MH
    A new era in cardio-renal risk management: overview of landmark papers published in NDT in 2021.
    Nephrol Dial Transplant. 2022;37:1003-1005.
    PubMed    


  64. VERNOOIJ RWM, Bots ML, Strippoli GFM, Canaud B, et al
    CONVINCE in the context of existing evidence on haemodiafiltration.
    Nephrol Dial Transplant. 2022;37:1006-1013.
    PubMed     Abstract available


  65. WACRENIER S, Riou J, Jourdain P, Guibert F, et al
    Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
    Nephrol Dial Transplant. 2022;37:1078-1087.
    PubMed     Abstract available


  66. HEWAWASAM E, Davies CE, Gulyani A, Li Z, et al
    Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years.
    Nephrol Dial Transplant. 2022;37:1152-1161.
    PubMed     Abstract available


  67. SCHMIEDER RE
    Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.
    Nephrol Dial Transplant. 2022 May 25. pii: 6592154. doi: 10.1093.
    PubMed     Abstract available


  68. BACHLE H, Sekula P, Schlosser P, Steinbrenner I, et al
    Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study.
    Nephrol Dial Transplant. 2022 May 24. pii: 6591612. doi: 10.1093.
    PubMed     Abstract available


  69. TANAKA M, Mori K, Takahashi S, Higashiura Y, et al
    Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than does fatty liver or nonalcoholic fatty liver disease.
    Nephrol Dial Transplant. 2022 May 24. pii: 6591613. doi: 10.1093.
    PubMed     Abstract available


  70. TORRES PU, Troya MI, Dauvergne M, Bover J, et al
    Correction to: Independent effects of parathyroid hormone and phosphate levels on hard outcomes in non-dialysis patients: food for thought.
    Nephrol Dial Transplant. 2022 May 20. pii: 6589624. doi: 10.1093.
    PubMed    


  71. ARIF Y, Wenziger C, Hsiung JT, Edward A, et al
    Association of serum potassium with decline in residual kidney function in incident hemodialysis patients.
    Nephrol Dial Transplant. 2022 May 13. pii: 6585673. doi: 10.1093.
    PubMed     Abstract available


  72. STEINBRENNER I, Sekula P, Kotsis F, von Cube M, et al
    Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study.
    Nephrol Dial Transplant. 2022 May 7. pii: 6582232. doi: 10.1093.
    PubMed     Abstract available


  73. WEN W, Portales-Castillo I, Seethapathy R, Krinsky S, et al
    Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients - a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 May 6. pii: 6581606. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  74. LEENEN E, Erger F, Altmuller J, Wenzel A, et al
    Alport syndrome and autosomal dominant tubulointerstitial kidney disease frequently underlie end stage renal disease of unknown origin - a single center analysis.
    Nephrol Dial Transplant. 2022 Apr 29. pii: 6575901. doi: 10.1093.
    PubMed     Abstract available


  75. DI MARIO F, Regolisti G, Maggiore U, Pacchiarini MC, et al
    Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
    Nephrol Dial Transplant. 2022 Apr 27. pii: 6575048. doi: 10.1093.
    PubMed     Abstract available


  76. BROWN M, Chou A, Li C, Farshid S, et al
    Survival, symptoms and hospitalisation of older patients with advanced CKD managed without dialysis.
    Nephrol Dial Transplant. 2022 Apr 19. pii: 6570719. doi: 10.1093.
    PubMed     Abstract available



  77. Correction to: Impact of pre-graft serology on risk of BKPyV infection post-renal transplantation.
    Nephrol Dial Transplant. 2022 Apr 19. pii: 6570888. doi: 10.1093.
    PubMed    


  78. CASTELLI C, Foucher Y, Boucquemont J, Prezelin-Reydit M, et al
    Impact of kidney transplantation in obese candidates: a time-dependent propensity score matching study.
    Nephrol Dial Transplant. 2022 Apr 19. pii: 6570721. doi: 10.1093.
    PubMed     Abstract available


  79. FRIED L, Schmedt N, Folkerts K, Bowrin K, et al
    High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database.
    Nephrol Dial Transplant. 2022 Apr 7. pii: 6564744. doi: 10.1093.
    PubMed     Abstract available


  80. WUERZNER G, Pruijm M, Burnier M
    Defining intradialytic hypertension: the importance of measuring blood pressure accurately.
    Nephrol Dial Transplant. 2022 Apr 1. pii: 6562093. doi: 10.1093.
    PubMed    


    March 2022
  81. MARKOSSIAN TW, Samra MK, Huisingh-Scheetz M, Wadhwa A, et al
    Framework to reduce frailty in hemodialysis patients.
    Nephrol Dial Transplant. 2022 Mar 28. pii: 6555042. doi: 10.1093.
    PubMed    


  82. BATAILLE S, Dou L, Bartoli M, Sallee M, et al
    Mechanisms of myostatin and activin A accumulation in chronic kidney disease.
    Nephrol Dial Transplant. 2022 Mar 25. pii: 6554261. doi: 10.1093.
    PubMed     Abstract available


  83. REHNBERG J, Ludvigsson JF, Carrero JJ, Emilsson L, et al
    Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study.
    Nephrol Dial Transplant. 2022;37:749-759.
    PubMed     Abstract available


  84. BRUNORI G, Aucella F
    Chosing the best renal care for our patients: the evolving landscape of dialysis therapy.
    Nephrol Dial Transplant. 2022;37:617-619.
    PubMed    


  85. LUBETZKY M, Zhao Z, Sukhu A, Sharma V, et al
    Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.
    Nephrol Dial Transplant. 2022 Mar 22. pii: 6552145. doi: 10.1093.
    PubMed    


  86. HAMANO T, Imaizumi T, Hasegawa T, Fujii N, et al
    Biopsy-proven CKD etiology and outcomes: Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Nephrol Dial Transplant. 2022 Mar 22. pii: 6552146. doi: 10.1093.
    PubMed     Abstract available


  87. YEE-MOON WA
    Comparing survival between home hemodialysis and peritoneal dialysis - is the controversy over?
    Nephrol Dial Transplant. 2022 Mar 15. pii: 6548903. doi: 10.1093.
    PubMed    


  88. DE NICOLA L, Serra R, Provenzano M, Minutolo R, et al
    Risk of end stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicenter unmatched and propensity-score matched analyses.
    Nephrol Dial Transplant. 2022 Mar 12. pii: 6547760. doi: 10.1093.
    PubMed     Abstract available


  89. COUCHOUD C, Bechade C, Kolko A, Baudoin AC, et al
    Dialysis-network variability in home dialysis use not explained by patient characteristics: a national registry-based cohort study in France.
    Nephrol Dial Transplant. 2022 Mar 7. pii: 6543724. doi: 10.1093.
    PubMed     Abstract available


  90. BRES E, Pagan C, Bouchara A, Pastural M, et al
    3-methylhistidine and clinical outcomes in maintenance hemodialysis patients.
    Nephrol Dial Transplant. 2022 Mar 2. pii: 6540981. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  91. YAN P, Duan SB, Luo XQ, Zhang NY, et al
    Development and validation of a deep neural network-based model to predict acute kidney injury following intravenous administration of iodinated contrast media in hospitalized patients with chronic kidney disease: a multicohort analysis.
    Nephrol Dial Transplant. 2022 Feb 26. pii: 6537417. doi: 10.1093.
    PubMed     Abstract available


  92. LAVILLE SM, Couturier A, Lambert O, Metzger M, et al
    Urea levels and cardiovascular disease in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 26. pii: 6537416. doi: 10.1093.
    PubMed     Abstract available


  93. IMAMURA K, Yamamoto S, Suzuki Y, Yoshikoshi S, et al
    Comparison of the association between six different frailty scales and clinical events in patients on hemodialysis.
    Nephrol Dial Transplant. 2022 Feb 25. pii: 6536926. doi: 10.1093.
    PubMed     Abstract available


  94. PIZZARELLI F, Basile C
    Do we have to rely on metric-based quality improvement strategies for the management of ESKD?
    Nephrol Dial Transplant. 2022;37:397-399.
    PubMed    


  95. DE JONG RW, Stel VS, Rahmel A, Murphy M, et al
    Patient-reported factors influencing the choice of their kidney replacement treatment modality.
    Nephrol Dial Transplant. 2022;37:477-488.
    PubMed     Abstract available


  96. VOOREND CGN, van Oevelen M, Verberne WR, van den Wittenboer ID, et al
    Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 Feb 23. pii: 6534933. doi: 10.1093.
    PubMed     Abstract available


  97. IMASAWA T, Saito C, Kai H, Iseki K, et al
    Long-term Effectiveness of a Primary Care Practice Facilitation Program for Chronic Kidney Disease Management: An Extended Follow-up of a Cluster-Randomized FROM-J Study.
    Nephrol Dial Transplant. 2022 Feb 23. pii: 6534934. doi: 10.1093.
    PubMed     Abstract available


  98. MANLEY HJ, Aweh G, Frament J, Ladik V, et al
    A real world comparison of HepB (Engerix-B(R)) and HepB-CpG (Heplisav-B(R)) vaccine seroprotection in patients receiving maintenance dialysis.
    Nephrol Dial Transplant. 2022 Feb 12. pii: 6527595. doi: 10.1093.
    PubMed     Abstract available


  99. LANO G, Sallee M, Pelletier M, Bataille S, et al
    Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis.
    Nephrol Dial Transplant. 2022 Feb 10. pii: 6526681. doi: 10.1093.
    PubMed     Abstract available


  100. BARRATT J, Andric B, Tataradze A, Schomig M, et al
    Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A phase 3, randomised, 6 open-label, active-controlled study (DOLOMITES).
    Nephrol Dial Transplant. 2022 Feb 10. pii: 6526678. doi: 10.1093.
    PubMed    


  101. MEIJERS B, Goedgezelschap A, Peeters D, Van Der Veen A, et al
    Heterologous vs. homologous triple anti-COVID-19 vaccine regimens in patients on maintenance hemodialysis.
    Nephrol Dial Transplant. 2022 Feb 9. pii: 6524916. doi: 10.1093.
    PubMed    


  102. TUNGSANGA S, Katavetin P, Panpetch W, Udompornpitak K, et al
    Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules.
    Nephrol Dial Transplant. 2022 Feb 9. pii: 6524921. doi: 10.1093.
    PubMed     Abstract available


  103. CHEN JHC, Brown MA, Jose M, Brennan F, et al
    Erratum to: Temporal changes and risk factors for death from early withdrawal within 12 months of dialysis initiation-a cohort study.
    Nephrol Dial Transplant. 2022 Feb 8. pii: 6524783. doi: 10.1093.
    PubMed    


  104. PEPIN M, Ferreira AC, Arici M, Bachmann M, et al
    Erratum to: Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.
    Nephrol Dial Transplant. 2022 Feb 8. pii: 6524784. doi: 10.1093.
    PubMed    


  105. KOLLAND M, Riedl R, Bachler B, Ribitsch W, et al
    Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis.
    Nephrol Dial Transplant. 2022 Feb 7. pii: 6523369. doi: 10.1093.
    PubMed    


  106. BORRELLI S, Mallamaci F, Chiodini P, Garofalo C, et al
    Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 7. pii: 6523367. doi: 10.1093.
    PubMed    


  107. LEENDERS NHJ, Bos C, Hoekstra T, Schurgers LJ, et al
    Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 3. pii: 6521456. doi: 10.1093.
    PubMed     Abstract available


  108. BOUDHABHAY I, Serris A, Servais A, Planas D, et al
    COVID-19 outbreak in vaccinated patients from a hemodialysis unit: antibody titers as a marker of protection from infection.
    Nephrol Dial Transplant. 2022 Feb 1. pii: 6519271. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  109. KOHMER N, Rabenau HF, Ciesek S, Kramer BK, et al
    Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.
    Nephrol Dial Transplant. 2022 Jan 31. pii: 6517745. doi: 10.1093.
    PubMed     Abstract available


  110. VAN DER WILLIK EM, Lengton R, Hemmelder MH, Hoogeveen EK, et al
    Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms - results from the RENINE/PROMs registry.
    Nephrol Dial Transplant. 2022 Jan 31. pii: 6517747. doi: 10.1093.
    PubMed     Abstract available


  111. LEES JS, Elyan BMP, Herrmann SM, Lang NN, et al
    The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes.
    Nephrol Dial Transplant. 2022 Jan 28. pii: 6516942. doi: 10.1093.
    PubMed     Abstract available


  112. MARROQUIN MV, Sy J, Kleine CE, Oveyssi J, et al
    Association of pre-ESKD hyponatremia with post-ESKD outcomes among incident ESKD patients.
    Nephrol Dial Transplant. 2022;37:358-365.
    PubMed     Abstract available


  113. VIGGIANO D, Capasso G
    How much time does it take to get cognitive impairment in kidney disease?
    Nephrol Dial Transplant. 2022;37:203-204.
    PubMed    


  114. GOUGEON F, Singh HK, Nickeleit V
    Renal comorbidities in collapsing variant focal segmental glomerulosclerosis: more than a coincidence?
    Nephrol Dial Transplant. 2022;37:311-317.
    PubMed     Abstract available


  115. SNOEK R, van Jaarsveld RH, Nguyen TQ, Peters EDJ, et al
    Genetics-first approach improves diagnostics of ESKD patients <50 years old.
    Nephrol Dial Transplant. 2022;37:349-357.
    PubMed     Abstract available


  116. HEMMELDER MH, Noordzij M, Vart P, Hilbrands LB, et al
    Recovery of dialysis patients with COVID-19: Health outcomes 3 months after diagnosis in ERACODA.
    Nephrol Dial Transplant. 2022 Jan 14. pii: 6507563. doi: 10.1093.
    PubMed     Abstract available


  117. ZHI R, Zhang XD, Hou Y, Jiang KW, et al
    RtNet: a deep hybrid neural networks for the identification of acute rejection and chronic allograft nephropathy after renal transplantation using multiparametric MRI.
    Nephrol Dial Transplant. 2022 Jan 10. pii: 6502368. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  118. DANSIE KB, Davies CE, Morton RL, Hawley CM, et al
    The IDEAL trial in Australia and New Zealand: clinical and economic impact.
    Nephrol Dial Transplant. 2021;37:168-174.
    PubMed     Abstract available


  119. NELVEG-KRISTENSEN KE, Szpirt W, Carlson N, McClure M, et al
    Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study.
    Nephrol Dial Transplant. 2021;37:63-71.
    PubMed     Abstract available


  120. JAMES LJ, Wong G, Tong A, Craig JC, et al
    Patient preferences for cancer screening in chronic kidney disease: a best-worst scaling survey.
    Nephrol Dial Transplant. 2021 Dec 27. pii: 6484819. doi: 10.1093.
    PubMed     Abstract available


  121. DANNEVILLE I, Beaumier M, Chatelet V, Boyer A, et al
    Are sex differences in the outcome of peritoneal dialysis explained by nurse-assistance? A cohort study with data from the RDPLF.
    Nephrol Dial Transplant. 2021 Dec 10. pii: 6459211. doi: 10.1093.
    PubMed     Abstract available


  122. WIJTVLIET VPWM, Arien KK, Abrams S, Couttenye MM, et al
    mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
    Nephrol Dial Transplant. 2021 Dec 9. pii: 6458368. doi: 10.1093.
    PubMed    


  123. DE ALARCON R, Alburquerque-Gonzalez B, Fernandez-Valera A, Molina-Nunez M, et al
    Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism.
    Nephrol Dial Transplant. 2021 Dec 9. pii: 6458371. doi: 10.1093.
    PubMed    


  124. MOLNAR AO, Bota SE, Naylor K, Nash DM, et al
    Opioid prescribing practices in chronic kidney disease: a population-based cohort study.
    Nephrol Dial Transplant. 2021 Dec 9. pii: 6458366. doi: 10.1093.
    PubMed     Abstract available


  125. HALFON M, Bachelet D, Hanouna G, Dema B, et al
    CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.
    Nephrol Dial Transplant. 2021;36:2256-2262.
    PubMed     Abstract available


  126. SCHAEFFNER E
    Smoothing transition to dialysis to improve early outcomes after dialysis initiation among old and frail adults - a narrative review.
    Nephrol Dial Transplant. 2021 Dec 1. pii: 6447544. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  127. CHU NM, Hong J, Harasemiw O, Chen X, et al
    Chronic kidney disease, physical activity, and cognitive function in older adults- results from the National Health and Nutrition Examination Survey (2011-2014).
    Nephrol Dial Transplant. 2021 Nov 25. pii: 6440170. doi: 10.1093.
    PubMed     Abstract available


  128. WATSON EL, Baker LA, Wilkinson TJ, Gould DW, et al
    Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease.
    Nephrol Dial Transplant. 2021 Nov 22. pii: 6433197. doi: 10.1093.
    PubMed     Abstract available


  129. CHU C, Chen X, Hasan AA, Szakallova A, et al
    Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis.
    Nephrol Dial Transplant. 2021 Nov 18. pii: 6430873. doi: 10.1093.
    PubMed     Abstract available


  130. CAUSLAND FRM, Ravi KS, Curtis KA, Kibbelaar ZA, et al
    A randomized controlled trial of two dialysate sodium concentrations in hospitalized hemodialysis patients.
    Nephrol Dial Transplant. 2021 Nov 18. pii: 6430877. doi: 10.1093.
    PubMed     Abstract available


  131. STUMPF J, Klimova A, Mauer R, Steglich A, et al
    Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and hemodialysis patients using mRNA vaccines.
    Nephrol Dial Transplant. 2021 Nov 15. pii: 6428414. doi: 10.1093.
    PubMed    


  132. EINBINDER Y, Hornik-Lurie T, Cohen-Hagai K, Goldman S, et al
    Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
    Nephrol Dial Transplant. 2021 Nov 12. pii: 6426118. doi: 10.1093.
    PubMed    


  133. QUIROGA B, Soler MJ, Ortiz A, Vaquera SM, et al
    Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
    Nephrol Dial Transplant. 2021 Nov 12. pii: 6426121. doi: 10.1093.
    PubMed     Abstract available


  134. ONISCU GC, Abramowicz D, Bolignano D, Gandolfini I, et al
    Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the Descartes working group of ERA.
    Nephrol Dial Transplant. 2021 Nov 12. pii: 6426119. doi: 10.1093.
    PubMed     Abstract available


  135. GOFFIN E, Candellier A, Vart P, Noordzij M, et al
    COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study.
    Nephrol Dial Transplant. 2021;36:2094-2105.
    PubMed     Abstract available


  136. MINUTOLO R, Gabbai FB, Agarwal R, Garofalo C, et al
    Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care.
    Nephrol Dial Transplant. 2021;36:2000-2007.
    PubMed     Abstract available


  137. HARDING JL, Morton JI, Shaw JE, Patzer RE, et al
    Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the United States and Australia.
    Nephrol Dial Transplant. 2021 Nov 1. pii: 6415215. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  138. PEPIN M, Ferreira AC, Arici M, Bachman M, et al
    Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment.
    Nephrol Dial Transplant. 2021 Oct 31. pii: 6414898. doi: 10.1093.
    PubMed     Abstract available


  139. LIABEUF S, Pepin M, Franssen CFM, Viggiano D, et al
    Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
    Nephrol Dial Transplant. 2021 Oct 31. pii: 6414896. doi: 10.1093.
    PubMed     Abstract available


  140. TORRES PU, Troya MI, Dauverge M, Bover J, et al
    Independent effects of parathyroid hormone and phosphate levels on hard outcomes in non-dialysis patients: food for thought.
    Nephrol Dial Transplant. 2021 Oct 28. pii: 6413562. doi: 10.1093.
    PubMed    


  141. WAKASUGI M, Kazama JJ, Nitta K, Narita I, et al
    Smoking and risk of fractures requiring hospitalization in hemodialysis patients: a nationwide cohort study in Japan.
    Nephrol Dial Transplant. 2021 Oct 27. pii: 6412547. doi: 10.1093.
    PubMed     Abstract available


  142. ROBERT T, Lano G, Giot M, Fourie T, et al
    Humoral response after SARS-COV2 vaccination in patient undergoing maintenance hemodialysis: loss of immunity, third dose and non-responders.
    Nephrol Dial Transplant. 2021 Oct 13. pii: 6395319. doi: 10.1093.
    PubMed    


  143. SANTOS-ARAUJO C, Veiga PM, Santos MJ, Santos L, et al
    Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in hemodialysis patients: a multicenter study.
    Nephrol Dial Transplant. 2021 Oct 11. pii: 6388402. doi: 10.1093.
    PubMed     Abstract available


  144. NATAATMADJA M, Zhao J, McCullough K, Fuller DS, et al
    International peritoneal dialysis training practices and the risk of peritonitis.
    Nephrol Dial Transplant. 2021 Oct 11. pii: 6388401. doi: 10.1093.
    PubMed     Abstract available


  145. RAMBABOVA-BUSHLJETIK I, Metzger J, Siwy J, Dohcev S, et al
    Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
    Nephrol Dial Transplant. 2021 Oct 11. pii: 6388403. doi: 10.1093.
    PubMed     Abstract available


  146. PAI AY, Sy J, Kim J, Kleine CE, et al
    Association of serum globulin with all-cause mortality in incident hemodialysis patients.
    Nephrol Dial Transplant. 2021 Oct 7. pii: 6383009. doi: 10.1093.
    PubMed     Abstract available


  147. NANO J, Schottker B, Lin JS, Huth C, et al
    Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population.
    Nephrol Dial Transplant. 2021 Oct 6. pii: 6382139. doi: 10.1093.
    PubMed     Abstract available


  148. CHEN JJ, Lee TH, Tu YK, Kuo G, et al
    Pharmacological and Nonpharmacological Treatments for Restless Legs Syndrome in End Stage Kidney Disease: A Systematic Review and Component Network Meta-Analysis.
    Nephrol Dial Transplant. 2021 Oct 6. pii: 6382141. doi: 10.1093.
    PubMed     Abstract available


  149. BUTLER CR, Johansen KL
    Beyond exercise: supporting a range of physical activity for people receiving dialysis.
    Nephrol Dial Transplant. 2021 Oct 5. pii: 6381710. doi: 10.1093.
    PubMed    


  150. GREZE C, Pereira B, Boirie Y, Guy L, et al
    Impact of obesity in kidney transplantation: a prospective cohort study from French registries between 2008 and 2014.
    Nephrol Dial Transplant. 2021 Oct 5. pii: 6381714. doi: 10.1093.
    PubMed     Abstract available


  151. CHAN GC, Than WH, Kwan BC, Lai KB, et al
    Adipose expression of miR-130b and miR-17-5p with wasting, cardiovascular event and mortality in advanced chronic kidney disease patients.
    Nephrol Dial Transplant. 2021 Oct 2. pii: 6380496. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  152. DOREILLE A, Godefroy R, Martzloff J, Delthombe C, et al
    French nationwide survey of undocumented ESRD migrant patient access to scheduled hemodialysis and kidney transplantation.
    Nephrol Dial Transplant. 2021 Sep 29. pii: 6377827. doi: 10.1093.
    PubMed    


  153. DAKROUB F, Touze A, Sater FA, Fiore T, et al
    The impact of pre-graft serology on the risk of BKPyV infection post-renal transplantation.
    Nephrol Dial Transplant. 2021 Sep 29. pii: 6377830. doi: 10.1093.
    PubMed     Abstract available


  154. OBERBAUER R, Meyer TW
    Corrigendum to: Precision medicine in transplantation and hemodialysis.
    Nephrol Dial Transplant. 2021 Sep 27. pii: 6376040. doi: 10.1093.
    PubMed    


  155. LOCATELLI F, Del Vecchio L
    Dialysis dose and mortality: where is the limit?
    Nephrol Dial Transplant. 2021 Sep 27. pii: 6375949. doi: 10.1093.
    PubMed    


  156. SOUWEINE JS, Pasquier G, Kuster N, Rodriguez A, et al
    Dynapaenia and sarcopaenia in chronic haemodialysis patients: do muscle weakness and atrophy similarly influence poor outcome?
    Nephrol Dial Transplant. 2021;36:1908-1918.
    PubMed     Abstract available


    August 2021
  157. GRAMS ME, Surapaneni A, Appel LJ, Lash JP, et al
    Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study.
    Nephrol Dial Transplant. 2021;36:1685-1693.
    PubMed     Abstract available


    July 2021
  158. REACH P, Touzot M, Lombardi Y, Maheas C, et al
    Electrochemical skin conductance by Sudoscan(R): a new tool to predict intradialytic hypotension.
    Nephrol Dial Transplant. 2021;36:1511-1518.
    PubMed     Abstract available


  159. HOPPE B, Pellikka PA, Dehmel B, Banos A, et al
    Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
    Nephrol Dial Transplant. 2021;36:1464-1473.
    PubMed     Abstract available


  160. KHOU V, De La Mata NL, Morton RL, Kelly PJ, et al
    Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand.
    Nephrol Dial Transplant. 2021;36:1527-1537.
    PubMed     Abstract available


  161. VERBERNE WR, van den Wittenboer ID, Voorend CGN, Abrahams AC, et al
    Health-related quality of life and symptoms of conservative care versus dialysis in patients with end-stage kidney disease: a systematic review.
    Nephrol Dial Transplant. 2021;36:1418-1433.
    PubMed     Abstract available


  162. TAWADA M, Ito Y, Banshodani M, Yamashita M, et al
    Vasculopathy plays an important role during the development and relapse of encapsulating peritoneal sclerosis with conventional peritoneal dialysis solutions.
    Nephrol Dial Transplant. 2021;36:1519-1526.
    PubMed     Abstract available


  163. PICKUP LC, Law JP, Townend JN, Ferro CJ, et al
    Sudden cardiac death in chronic renal disease: aetiology and risk reduction strategies.
    Nephrol Dial Transplant. 2021;36:1386-1388.
    PubMed    


    June 2021
  164. TYE SC, Denig P, Heerspink HJL
    Precision medicine approaches for diabetic kidney disease: opportunities and challenges.
    Nephrol Dial Transplant. 2021;36.
    PubMed     Abstract available


  165. SEIKRIT C, Rauen T, Stamellou E, Floege J, et al
    Precision medicine in immunoglobulin A nephropathy: still a journey ahead.
    Nephrol Dial Transplant. 2021;36.
    PubMed     Abstract available


    May 2021
  166. YEUNG EK, Polkinghorne KR, Kerr PG
    Home and facility haemodialysis patients: a comparison of outcomes in a matched cohort.
    Nephrol Dial Transplant. 2021;36:1070-1077.
    PubMed     Abstract available


  167. MURPHY E, Burns A, Murtagh FEM, Rooshenas L, et al
    The Prepare for Kidney Care Study: prepare for renal dialysis versus responsive management in advanced chronic kidney disease.
    Nephrol Dial Transplant. 2021;36:975-982.
    PubMed     Abstract available


  168. OGATA H, Shimofurutani N, Okada T, Nagamoto H, et al
    Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial.
    Nephrol Dial Transplant. 2021;36:1088-1097.
    PubMed     Abstract available


  169. LIN TY, Hung SC
    Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study.
    Nephrol Dial Transplant. 2021;36:1104-1111.
    PubMed     Abstract available


    April 2021
  170. SISE ME, McQuaid T, Martin P
    Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease.
    Nephrol Dial Transplant. 2021 Apr 12. pii: 6225011. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  171. HORACE RW, Roberts M, Shireman TI, Merhi B, et al
    Remnant cholesterol is prospectively associated with CVD events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
    Nephrol Dial Transplant. 2021 Mar 24. pii: 6184949. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  172. MALYSZKO J, Basak G, Batko K, Capasso G, et al
    Haematological disorders following kidney transplantation.
    Nephrol Dial Transplant. 2020 Nov 5. pii: 5956379. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  173. ETHIER I, Cho Y, Hawley C, Pascoe EM, et al
    Multicenter registry analysis comparing survival on home hemodialysis and kidney transplant recipients in Australia and New Zealand.
    Nephrol Dial Transplant. 2020 Sep 3. pii: 5900874. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: